Donor screening for hepatitis B virus infection in a cell and tissue bank

Transplant Infectious Disease

Volumn 10, Issue 6, 2008, Pages 391-395

  Solves, P ^a,b,e   Mirabet, V ^a,c   Alvarez, M ^a,d   Vila, E ^a,d   Quiles, F ^a,c   Villalba, J V ^a,d   Montoro, J A ^a,d   Soler, M A ^a,c   Roig, R J ^a  

^a Transfusion Center   (Spain)

^b Umbilical Cord Blood Bank   (Spain)

^c Cell and Tissue Bank   (Spain)

^d Serology and Molecular Biology   (Spain)

^e Valencia Transfusion Centre   (Spain)

Author keywords

Cord blood; Donor screening; Hepatitis B virus; Tissue bank

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DNA DETERMINATION; DONOR; FEMALE; HEALTH CARE FACILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVING DONOR; MALE; PRIORITY JOURNAL; SCREENING; SEROLOGY; UMBILICAL CORD BLOOD; VIRUS DETECTION; VIRUS TITRATION;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD TRANSFUSION; DNA, VIRAL; DONOR SELECTION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVING DONORS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; SPAIN; TISSUE BANKS; TISSUE DONORS; YOUNG ADULT;

EID: 56749180773     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00331.x     Document Type: Article

References (23)

1. Joyce MJ, Greenwald AS, Rigney R, et al. Report on musculoskeletal allograft tissue safety. Presented at the American Academy of Orthopaedic Surgeons 71st Annual Meeting, San Francisco, March 10-14, 2004.
2. Dodd RY. Current viral risks of blood and blood products. Ann Med 2000 32 : 469 474.
3. Alvarez M, Oyonarte S, Rodríguez PM. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002 42 : 994 997.
4. Zou S, Dodd RY, Stramer SL, Strong M. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004 351 : 751 759.
5. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 1990 30 : 431 432.
6. Villalba R, Fornes G, Eisman M, Gomez Villagrán JL. Evaluation of tissue discards after implementation of anti-HBc test in a tissue bank. Cell Tissue Bank 2007 8 : 303 305.
7. Zeiler T, Karger R, Slonka J, Ketschmer V. Introduction of anti-HBc testing of blood donors in Germany. Transfus Med 2006 16 : 441 443.
8. Colomina J, González D, Burgos A, Fernández N, Guerrero A. Significado de la reactividad aislada anti-HBc como único marcador de infección de la hepatitis B. Infec Microbiol Clin 2005 23 : 80 85.
9. Zanetti AR, Romano L, Zappa A, Velati C. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. J Clin Virol 2006 36 (Suppl 1) : S51 S55.
10. Blumberg BS. Australia antigen and the biology of hepatitis B. Science 1977 197 : 17 25.
11. Busch MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus Clin Biol 2004 11 : 26 32.
12. Bart PA, Jacquier P, Zuber PLF, Lavanchy D, Frei PC. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HBV infections among 9006 women at delivery. Liver 1996 16 : 110 115.
13. Manzini P, Girotto M, Borsotti R, et al. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 2007 92 : 1664 1670.
14. Roth WK. Hepatitis B and blood transfusion. ISBT Science series. Vox Sang 2007 92 : 178 183.
15. Comanor L, Holland P. Hepatitis B virus blood screening. Unfinished agendas. Vox Sang 2006 91 : 1 12.
16. Reesink HW, Engelfriet CP, Henn G, et al. Occult hepatitis B infection in blood donors. Vox Sang 2008 94 : 153 66.
17. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004 86 : 83 91.
18. Real Decreto 1301/2006, por el que se establecen las normas de calidad y seguridad para la donación, la oblención, la evaluación, el procesamiento, la preservación, el almacenamiento y la distribución de célulós y tejidos humanos y se aprueban las normas de coordinación y funcionamiento para su uso en humanos. Boletin Oficial del Estado 2006 270 : 39475 39502.
19. Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus. Nucleic acid testing versus immunoassay methods. Mol Diagn Ther 2006 10 : 77 91.
20. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999 107 : 186 195.
21. Lucey C. Brief report on the United States Food and Drug Administration Blood products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA. Vox Sang 2006 91 : 331 335.
22. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999 107 : 186 195.
23. Zanetti AR, Mariano A, Romanò L, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005 366 : 1379 1384.